Inclusive of all taxes
Abiraterone Acetate Tablets IP 250mg are prescription oncology tablets formulated for the treatment of metastatic castration-resistant prostate cancer (CRPC) and high-risk castration-sensitive prostate cancer (CSPC). This medicine is used as part of a clinician-directed prostate cancer treatment plan and is intended for use under medical supervision. The tablets should be taken exactly as prescribed and must be administered on an empty stomach for proper absorption. Patients should avoid food for 2 hours before and 1 hour after dosing, and the tablets should be swallowed whole with water without crushing or chewing. Abiraterone acetate is commonly prescribed in oncology settings where consistent dosing, adherence to administration instructions, and ongoing monitoring are essential. From a B2B healthcare procurement perspective, Abiraterone Acetate Tablets IP 250mg is a high-demand anti-cancer medicine used by hospitals, oncology clinics, cancer care centers, and licensed medical distributors. It is typically sourced in bottle packaging for controlled dispensing and institutional supply. Since treatment with abiraterone requires monitoring of liver function, blood pressure, and potassium levels, procurement teams and healthcare providers often look for authentic, export-ready supply with reliable packaging and batch traceability. This product listing is relevant for buyers seeking branded or generic oncology medicine supply for prostate cancer management. Key therapeutic considerations include monitoring for fluid retention, edema, hypertension, diarrhea, hypokalemia, and elevated liver enzymes. Because of these risks, use is generally restricted to patients under specialist supervision. Effective contraception is recommended when there is potential exposure to a pregnant partner. In B2B marketplaces, this medicine is typically categorized under oncology and anti-neoplastic pharmaceuticals, especially for prostate cancer treatment supply chains.
Key Features
| Features | Description |
|---|---|
| Product Name | Abiraterone Acetate Tablets IP 250mg |
| Therapeutic Use | Treatment of metastatic castration-resistant prostate cancer (CRPC) and high-risk castration-sensitive prostate cancer (CSPC) |
| Administration | Must be taken on an empty stomach; avoid food for 2 hours before and 1 hour after dosing |
| Dosage Form | Tablet |
| Packaging Unit | Bottle |
| Strength | 250 mg |
| Safety Monitoring | Requires regular monitoring of liver function, blood pressure, and potassium levels |
| Attributes | Description |
|---|---|
| Product Title | ABIRATERONE ACETATE TABLETS IP 250MG |
| Active Ingredient | Abiraterone Acetate |
| Strength | 250 mg |
| Dosage Form | Tablet |
| Packaging Type | Bottle |
| Indicative Use | Prostate cancer treatment |
| Primary Indication | Metastatic castration-resistant prostate cancer (CRPC) and high-risk castration-sensitive prostate cancer (CSPC) |
| Administration Requirement | Empty stomach |
| Food Restriction | Do not eat for 2 hours before and 1 hour after taking the tablet |
| Method of Administration | Swallow whole with water; do not crush or chew |
| Monitoring Required | LFT, blood pressure, and potassium |
| Common Side Effects | Fluid retention/edema, high blood pressure, diarrhea, hypokalemia, elevated liver enzymes |
| Precaution | Use effective contraception if engaging in sexual activity with a pregnant person |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
It is used for the treatment of metastatic castration-resistant prostate cancer (CRPC) and high-risk castration-sensitive prostate cancer (CSPC) under specialist supervision.
Food can significantly affect the absorption of abiraterone, so it must be taken on an empty stomach for consistent therapeutic effect.
Patients should not eat for 2 hours before taking the tablet and should avoid food for 1 hour after taking it.
Regular monitoring of liver function tests, blood pressure, and potassium levels is required due to the risk of liver enzyme elevation, hypertension, and hypokalemia.
No, the tablets should be swallowed whole with water and must not be crushed or chewed.
The product is listed in bottle packaging, which is suitable for controlled dispensing and institutional supply.
Country Of Origin: India
Inclusive of all taxes
You Save: 0
